CD44 Monoclonal / NovaFluor Blue 510 / IM7

Product Details
Supplier Thermo Fisher Scientific
Catalog #: M010T02B01-A (View supplier product page)
Size 25 μg
Price $183.00
Antigen CD44
Clone IM7
Host Rat
Isotype IgG2b κ
Conjugate NovaFluor Blue 510
Target Species Human, Mouse
Applications FC
Description CD44 Monoclonal Antibody (IM7), NovaFluor Blue 510, eBioscience
About CD44 and NovaFluor Blue 510
CD44 The protein encoded by this gene is a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion and migration. It is a receptor for hyaluronic acid (HA) and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). This protein participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms, however, the full length nature of some of these variants has not been determined. Alternative splicing is the basis for the structural and functional diversity of this protein, and may be related to tumor metastasis. [provided by RefSeq, Jul 2008]
NovaFluor Blue 510 The NovaFluor family of fluorescent polymers from Thermo Fisher Scientific are a novel reagent for traditional and spectral flow cytometry. These fluorophores are comprised of a DNA backbone polymer integrated with fluorophore substituted nucleosides to create a potent donor molecule. Tandem fluophores with long Stokes' Shift enable brighter, spectrally discrete, tunable fluorescent polymers as an alternative to traditional simple organic structures, protein-based fluorophores as well as the Horizon Brilliant™ family of fluorescent polymers from BD. NovaFluor Blue 510 is designed to be discreetly excited by the 488 nm laser and has an excitation peak at 496 nm and an emission peak at 511 nm.
Citations
Additional
Sources
Reviews & Ratings
Submit a Review

NovaFluor Blue 510 Excitation and Emission Spectra